Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-23
2007-01-23
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S194000
Reexamination Certificate
active
10646495
ABSTRACT:
Indolinones of general formula Iwhich are inhibitors of cell proliferation, particularly of tumor cells, and inhibitors of protein kinases.
REFERENCES:
patent: 6794395 (2004-09-01), Roth et al.
patent: 2004/0044222 (2004-03-01), Walter et al.
patent: 2004/0204458 (2004-10-01), Roth et al.
patent: 100 29 285 (2001-12-01), None
patent: 1 070 705 (2001-01-01), None
patent: WO 99 10325 (1999-03-01), None
patent: WO 99 15500 (1999-04-01), None
patent: WO 99 51574 (1999-10-01), None
patent: WO 00 55159 (2000-09-01), None
patent: WO 01 16130 (2001-03-01), None
patent: WO 01 27081 (2001-04-01), None
Heckel Armin
Kley Joerg
Lenter Martin
Roth Gerald
Schnapp Gisela
Anderson Rebecca
Boehringer Ingelheim Pharma GmbH & Co. KG
Devlin Mary-Ellen M.
McKane Joseph K.
Morris Michael P.
LandOfFree
Substituted indolinones, preparation thereof and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted indolinones, preparation thereof and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted indolinones, preparation thereof and their use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3788374